METHOD FOR ASSESSING POSSIBILITY OF ACHIEVING MINIMUM DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS Russian patent published in 2024 - IPC A61B5/02 G01N33/49 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to rheumatology, and can be used to assess the possibility of achieving minimum disease activity (MDA) in patients with psoriatic arthritis (PsA). Blood CRP level (X1), the number of enthesites according to the LEI index (X2), the presence of arterial hypertension (AH) in the patient (X3), the area of skin psoriasis BSA (X4), the patient’s body weight index (X5) are determined. Obtained data are used to determine the possibility of achieving the minimum disease activity in the patients with psoriatic arthritis (B). When obtaining value B≤1.184 predicts the achievement of MDA in the patient with PsA.

EFFECT: method enables assessing the possibility of achieving MDA in the patients with psoriatic arthritis with a high degree of reliability due to the availability of examination methods and the possibility of obtaining a result with the least amount of time.

1 cl, 1 dwg, 1 tbl, 2 ex